News About: R&D
Genome Project for Alcohol Producing Bacterium Completed
The research team of Macrogen Inc., a domestic biotechnology venture company, reported on the results from its genome-sequencing project of ethanologenic bacterium Zymomonas mobilis, in the on-line edition of Nature B...
Domestic Research Institute Continues Its R&D Strengths Under New Name
The Pharmaceutical Research Institute of Chung-Ang University has recently been renamed as the Institute for Molecules-Based New Drug Development, with continued focus on its R&D efforts in producing biotechnology-bas...
7.9 Billion Won Invested to Support New Drug R&D Next Year
The Ministry of Health and Welfare (MOHW) has finalized a total allocation of 24.3 billion won of its budget to support strategic investments on medical, pharmaceutical and biotechnology projects, covering one-year pe...
Joint International Research Efforts on Natural Ingredients and Their Applications
The research institute under the Kyung Hee University, which specializes in the areas of traditional and current pharmaceuticals, is actively establishing a collaborative relationship with universities from China, Jap...
Effects of Glutamine on Critically Ill Patients Discussed
In a recent symposium organized by a domestic university hospital and sponsored by Fresenius Kabi Korea, research findings on the effects of glutamine treatment to critically ill patients were presented.
A number o...
KRIBB team elucidates mechanism of active oxygen speciesKorean scientists, led by Dr. Rhy Seong-eon of Korea Research Institute of Bioscience and Biotechnology (KRIBB), said on November 15 that they had found out how the reactive oxy...
|
Bee venum alleviates rheumatoid arthritis
Bee venom has anti-arthritic effects in both sets of animals, said Professor Hong Jin-tae from Chungbuk National University in Korea and colleagues.
The recent report published in the journal Arthritis and Rheumati...
En-Bio Technology's microsatellite analysis patented in 17 countries
En-Bio Technology said on October 26 that Cangen Biotechnologies Inc. has acquired a patent for its platform microsatellite analysis (MSA) technology from 17 countries from Australia. The Korean company acquired a lar...
Domestic technology for placenta injectable near commercialized.It is near ready for the human placenta to be commercially available in Korea after due technology success in isolating and purifying the bio active substances from crude human ...
|
Long term efficacy and safety, essential in choice of hypertension drug.
It is well recommended for any ideal hypertension drug to make choice in terms of its long term efficacy and safety.
Seoul Internal Medicine Medical Association under the sponsorship of Pfizer Korea held a seminar...
